Monday, 30 June 2014
INDIAN EQUITY BENCHMARKS maintained its
momentum supported by heavy buying in financials, infra and power shares amid
strong global cues. Fiscal
deficit figures for the month of May and auto numbers for the month of June
will be announced today.
Further, Ranbaxy rose 3% extending its
Friday’s 5% rally, after US Food and Drug Administration's nod for generic
version of Novartis blood pressure drug Diovan. Cipla surged 0.8% after signing a
definitive agreement to acquire a 51% stake in a pharmaceuticals manufacturing
and distribution business in Yemen (owned by a UAE-based parent company) for
$21 million.
The
crucial resistance for Nifty is now seen at 7625 and above this 7665.
Support for the immediate term is now placed at 7530 and next
support will be 7480.
Get real
time advice for Stock Market, Forex, Comex. Stock trading tips, Forex,
Commodity like gold, silver, copper, crude trading tips and all market updates.
…<a href ='http://www.capitalstars.com/services.php'>Share Market
Tips</a>
